Skip to content

I Have RP Posts

Stem Cell Ophthalmology Treatment Study

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Stem Cell Ophthalmology Treatment Study Conditions:   Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   GlaucomaInterventions:   Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)Sponsor:   MD Stem CellsEnrolling by invitation Source: ClinicalTrials.gov – Retinitis Pigmentosa – Stem Cell Ophthalmology Treatment Study

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy Conditions:   Retinitis Pigmentosa;   Cone Rod Dystrophy;   ChoroideremiaIntervention:   Device: Intelligent Retinal Implant SystemSponsor:   Pixium Vision SAActive, not recruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – Restoring Vision With the Intelligent Retinal Implant System (IRIS…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

High Resolution Retinal Imaging

Source: ClinicalTrials.gov – Retinitis Pigmentosa – High Resolution Retinal Imaging Conditions:   Stargardts;   Retinitis Pigmentosa;   Age-related Macular Degeneration;   Choroideremia;   Geographic AtrophyIntervention:   Procedure: Retinal imagingSponsors:   University of Pennsylvania;   National Eye Institute (NEI)Recruiting – verified June 2017 Source: ClinicalTrials.gov – Retinitis Pigmentosa – High Resolution Retinal Imaging

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) Conditions:   Smith-Lemli-Opitz Syndrome;   Cone-Rod Dystrophy;   Hearing LossInterventions:   Drug: Antioxidants;   Drug: CholesterolSponsor:   University of Colorado, DenverRecruiting – verified August 2017 Source: ClinicalTrials.gov – Retinitis Pigmentosa – Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Source: ClinicalTrials.gov – Retinitis Pigmentosa – North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Conditions:   Mitochondrial Disorders;   Mitochondrial Genetic Disorders;   Mitochondrial Diseases;   Disorder of Mitochondrial Respiratory Chain Complexes;   Deletion and Duplication of Mitochondrial DNAIntervention:   Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)Recruiting – verified August 2017 …

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest